Consenting adult female patient felt by the provider to require gonorrhea/chlamydia endocervical testing will be asked to provide an additional self sample specimen. The specimen will be sent to the laboratory using conventional diagnostic test for gonorrhea/chlamydia.
Study protocol: 1. Initial emergency department history and physical examination (standard procedure). a. Provider identifies patient who is felt to require gonorrhea/chlamydia testing. i. Provider will contact study staff to consent patient. b. Study staff identifies patient who is felt by provider to require gonorrhea/chlamydia testing. i. Study staff will ask provider if they could move forward with consenting patient. c. Provider who is study staff identifies patient who is felt to require gonorrhea/chlamydia testing. 2. Study staff will attempt to consent patient. 1. If inclusion criteria are met, and there are no exclusion criteria, written informed consent is obtained. 2. If the patient changes her mind and refuses consent at this point, a notation is written on the front of the research packet, and it is turned in with a refusal notice on the packet. * If patient refuses to participate in the self-sampling portion of the study, we will ask patients if they would like to fill out the first half of the patient survey that will contain no personal identification information besides their initials. 3. If patient agrees to participate in the self-sampling, the patient is asked to fill out both page one and page two of the survey after consent is obtained. 4. An attempt is made to write down at least two contact telephone numbers for patients who have given informed consent on page 2 of the patient survey. 5. The patient obtains vaginal self-sample in the restroom/exam room. 1. A preprinted single-use instruction sheet is given to patient detailing sample collection. 2. Vaginal self-sampling collection container has preprinted instructions/requisition and a preprinted label on the Cepheid sample tube to the lab denoting this as research sample. 3. Paper requisition form is also included with the sample which helps with documentation and assigning this sample to be billed to the research study and not to the patient. 4. The patient returns the collection container after obtaining the sample to study staff that consented the patient. 5. The collection container will be sent to the lab via pneumatic tube station. 6. Vaginal self-sampling result is documented in Epic with designation showing differentiation from provider-performed endocervical sampling. 6. Provider-performed endocervical sampling is performed once the patient is assigned a provider and given a private area to conduct a provider-performed endocervical sampling (standard procedure). a. The collection container is sent to the lab, and the final result is noted in the medical record as per standard practice (standard procedure). 7. Retrospective chart review is performed three days after patient consented in order to obtain provider-performed endocervical sampling results. 8. Patient will be contacted only if there is a false-negative. A positive with either the self-sample or provider collected sample is considered positive, and patient will not be called back about that
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
533
This is a prospective, non-inferiority trial comparing two methods of collection using a US Food and Drug Administration- cleared 90-minute rapid nucleic acid amplification assay, the Xpert CT/NG assay. Any adult female patient admitted to the Emergency Department at Community Regional Medical Center felt by the provider to require gonorrhea/chlamydia endocervical testing may be entered in the study.
provider-performed endocervical sampling is the gold standard for both gonorrhea and chlamydia. The provider takes a endocervical sample which will get sent to the laboratory as the standard care in comparison to the device being studied.
Community Regional Trauma and Burn Center
Fresno, California, United States
Noninferiority of vaginal self-sampling compared to provider performed endocervical sampling for gonorrhea/chlamydia diagnosis
In order for vaginal self-sampling to be considered clinically noninferior to the standard provider-performed endocervical sampling method of collection, we established a minimum sensitivity of 90%. This was based on previous research showing Sexually Transmitted Infection (STI) clinicians' top priority for a point of care STI test is a minimum sensitivity of 90%. In addition, a previous ED study examining urine gonorrhea/chlamydia diagnosis using the same point of care test as this study also used a minimum sensitivity of 90%. (9) Thus, our primary outcome measure was examining for the noninferiority of VSS sensitivity for gonorrhea/chlamydia, with noninferiority being demonstrated if the sensitivity is \>=90%.
Time frame: 2-3 days
Predictive value
Vaginal self-sampling specificity, positive predictive value, negative productive value for gonorrhea/chlamydia (measured by individual patient)
Time frame: 2-3 days
Predictive value-Gonorrhea
Vaginal self-sampling sensitivity, specificity, positive predictive value, negative predictive value for gonorrhea
Time frame: 2-3 days
Predictive value-Chlamydia
Vaginal self-sampling sensitivity, specificity, positive predictive value, negative predictive value for chlamydia
Time frame: 2-3 days
Demographics
Concordance of vaginal self-sampling to provider-performed endocervical sampling
Time frame: 2-3 days
Percentage
Acceptance rate vaginal self-sample
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: 2-3 days
Rate-Worried
Rate of patients worried about doing vaginal self-sampling and correctly
Time frame: 2-3 days
Rate-Prefer
Rate of patients that prefer vaginal self-sample to provider-performed endocervical sampling
Time frame: 2-3 days
Numeric
Number of patients that refused vaginal self-sampling
Time frame: 2-3 days
Descriptive
Description of reasons for refusal of vaginal self-sampling
Time frame: 2-3 days